Search - tctmd.com

Displaying 801 - 820 of 829

Sort: Relevancy | Date

News Conference News ESC 2015

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

Caitlin E. Cox

August 31, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Daily News

Study Supports Use of Low-Dose Aspirin After Acute MI

Todd Neale

May 28, 2015

News Daily News

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

May 14, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Jason Kahn

October 11, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

November 28, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

L.A. McKeown

June 01, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

Advertisement

OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Study Supports Use of Low-Dose Aspirin After Acute MI

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content